Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI)
Mission: A collaborative partnership between UMB and UMCP focused on modernizing and improving the ways drugs and medical devices are reviewed and evaluated.
Funded by the U.S. Food and Drug Administration (FDA), M-CERSI joins researchers from both campuses with FDA staff to support the development of new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products.
In 2018, M-CERSI introduced Master of Science in Regulatory Science.
In August 2023, the FDA renewed funding under a new five-year cooperative agreement, making M-CERSI one of only five FDA-funded CERSIs in the country and the oldest. In November 2023, M-CERSI’s Co-Director, James E. Polli, PhD, was named an MPower Professor.